In recent years, the injections known as Ozempic became almost a global phenomenon. Initially, they were recognized for their properties in controlling type 2 diabetes. However, they quickly gained fame for a different reason: aiding in weight loss.
Celebrities, digital influencers, and ordinary people share their experiences with this medicine online. Given their success, more vocational variants for weight loss, such as WeGovy and Zepbound, have rapidly emerged.
While the popularity of these drugs grows, the scientific community is also dedicated to investigating the widest impact of these substances on human health. The latest discoveries are at least curious.
A recent study, published in the prestigious scientific journal JAMA Network Open, suggests that these medications can have benefits far beyond weight balance and diabetes management.
The examination accompanied 60,000 people with obesity and type 2 diabetes for seven years. half of the participants received treatments with GLP-1 receptor agonists (type 1 glucagon peptide, a hormone involved in blood sugar regulation and appetite control), such as Wegovy and Mounjaro. The othre half took conventional antidiabetic medications.
The results were surprising: those using these injectable drugs had a 37% lower risk of developing dementia and a 19% reduction in the risk of stroke by the end of the study.
Study authors suggest that these injections may offer neuroprotective and vascular benefits, beyond simple blood glucose control. In adults with type 2 diabetes and obesity, they appear to improve long-term health perspectives.
Though, scientists stress the necessity of deepening research to determine if the effects on the brain and blood vessels are direct or merely a result of the general betterment in metabolic health. “It is indeed very likely that effectively controlling diabetes and obesity helps reduce the risk of dementia and stroke, as we certainly know they are clear risk factors,” says professor Tara Spires-Jones, from the Center for Brain Sciences at Edinburgh University.
7 · Compliance & Disclaimers
This content is for informational purposes only and does not constitute medical, financial, or legal advice.Consult with qualified professionals for personalized guidance.
8 · Call-to-Action
What are your thoughts on these groundbreaking findings? Share your insights in the comments below and subscribe to World Today News for more cutting-edge health updates!
